Sponsor:
National Eye Institute (NEI)
Code:
NCT02617966
Conditions
Retinal Degeneration
Retinitis Pigmentosa
Stargardt's Disease
Eligibility Criteria
Sex: All
Age: 5 - 70+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Retinal Degeneration
Retinitis Pigmentosa
Stargardt's Disease
Study ID
NCT02617966
Start date
Mar 24, 2016
Status verified date
Aug 18, 2026
Completion date
Dec 30, 2029
Anticipated
Primary completion date
Dec 30, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 5 - 70+
Healthy Volunteers: Accepted
Enrollment
500 participants
Anticipated
Arms
Affected
Unaffected
Primary outcome measure
Central contacts
Locations
National Institutes of Health Clinical Center
Recruiting
Bethesda, Maryland, United States, 20892
Sponsor
National Eye Institute (NEI)
Last update posted
Aug 31, 2026
Last verified
Aug 18, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-07. This information was provided to ClinicalTrials.gov by National Eye Institute (NEI) on 2026-08-31. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.